Shenzhen Zhendejici Pharmaceutical Research and Development

Shenzhen Zhendejici Pharmaceutical Research and Development is a biotechnology company focused on the innovation of molecular imaging agents and precision diagnostic technologies. The company utilizes a proprietary self-assembling platform based on CBT-Cys click chemistry to develop smart probes that respond to specific biological microenvironments. These agents are designed to enhance the sensitivity and specificity of Magnetic Resonance Imaging (MRI) and optical imaging for early cancer detection and intraoperative guidance. By integrating chemical biology with medical imaging, Zhendejici aims to provide high-performance diagnostic tools that improve patient outcomes through earlier and more accurate disease identification.